Inhibition of Transforming Growth Factor (TGF)-β1–Induced Extracellular Matrix with a Novel Inhibitor of the TGF-β Type I Receptor Kinase Activity: SB-431542
Nicholas J. Laping(GlaxoSmithKline (United Kingdom)), Eugene T. Grygielko(GlaxoSmithKline (United Kingdom)), Anil Mathur(GlaxoSmithKline (United States)), Sebastian Butter(GlaxoSmithKline (United States)), Jennifer M. Bomberger(GlaxoSmithKline (United Kingdom)), Christopher Tweed(GlaxoSmithKline (United States)), W. Martin(GlaxoSmithKline (United Kingdom)), James A. Fornwald(GlaxoSmithKline (United States)), Ruth Lehr(GlaxoSmithKline (United Kingdom)), John D. Harling(GlaxoSmithKline (United States)), Laramie M. Gaster(GlaxoSmithKline (United States)), James F. Callahan(GlaxoSmithKline (United Kingdom)), Barbara A. Olson(GlaxoSmithKline (United Kingdom))
Cited by 650
Abstract
Related Papers
No related papers found
Powered by citation graph analysis